Clarity Pharmaceuticals Ltd Sustainability Reports

Clarity Pharmaceuticals Ltd is a clinical-stage radiopharmaceutical company focused on developing next-generation products for the treatment of serious diseases. The company utilizes its proprietary SAR Technology platform to develop targeted copper theranostics for oncology applications in children and adults.

Sector: Manufacturing

Country: Australia

Exchange: Australian Securities Exchange

LEI: 894500870CF75LRT6F56

FIGI: BBG011WVJ0S1

12 reports from 2021 to 2025

• Clarity Pharmaceuticals Ltd 2025 Corporate Governance Statement
• Clarity Pharmaceuticals Ltd 2025 Annual Report
• Clarity Pharmaceuticals Ltd 2024 Corporate Governance Statement
• Clarity Pharmaceuticals Ltd 2024 Annual Report
• Clarity Pharmaceuticals Ltd 2023 Corporate Governance Statement